Please provide your email address to receive an email when new articles are posted on . EASI 75 and validated IGA-AD 0/1 response rates from week 16 were maintained through week 140. No new safety ...

AbbVie's strong results, pipeline wins, and Rinvoq exclusivity boost its outlook. Read the latest analysis on ABBV stock here.

HOW COMMERCIAL INSURERS PUT THE SQUEEZE ON PROVIDERS: Hospitals and health systems in Illinois and around the country find themselves struggling to collect payments for health care they've provided, ...

Shares of AbbVie Inc. (ABBV) hit a fresh record high on Thursday before paring back some of the gains, after the company said it does not expect any generic versions of its Rinvoq in the U.S. before ...

(Reuters) -AbbVie raised its annual profit forecast after strong sales of its newer immunology drugs and key cancer treatment helped the company beat Wall Street estimates for third-quarter earnings, ...